VitalisPharma SRL
VitalisPharma reported total assets of 45,436 € at the end of the 2025 financial year (annual accounts filed with the NBB on 21 Apr 2026).
The score of VitalisPharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
VitalisPharma's annual accounts
| 2025 | |
|---|---|
| Net result | −17,576 € |
| Equity | −12,576 € |
| Cash | 5,841 € |
| EBITDA | −15,883 € |
| Total assets | 45,436 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Apr 2026
VitalisPharma's financial analysis
- Solvency-27.7%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of VitalisPharma
VitalisPharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1025.210.222
- VAT number
- BE1025210222
- Peppol
- Registered · 0208:1025210222 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Jul 2025
- Registered office
- 1140 Evere
- Latest accounts
- 2025 · filed on 21 Apr 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
VitalisPharma (SRL) has been based in Evere since 2025, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 17,576 € and equity of −12,576 €; its revenue is not published. Its solvency stands at -27.7%, below the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to VitalisPharma
Companies in the same business, of comparable size and area, outside its group.
- AVICENNE Pharma Services Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 42,747 €
- NZpharma Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 74,203 €
- Laphare Retail sale of pharmaceutical products Mettet · balance sheet 49,090 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- ELI Retail sale of pharmaceutical products Genk · balance sheet 53,448 €
- Pharmacie Marievoet Retail sale of pharmaceutical products Auderghem · balance sheet 60,288 €
- OKINEO System Retail sale of pharmaceutical products Colfontaine · balance sheet 64,459 €
- Apotheker Laura Spiritus Retail sale of pharmaceutical products Linter · balance sheet 62,639 €
Frequently asked questions about VitalisPharma
What is the revenue of VitalisPharma?
VitalisPharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of VitalisPharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1025210222 for VitalisPharma, if the company is VAT-registered. Its company number (CBE) is 1025.210.222.
Where is the registered office of VitalisPharma?
According to the CBE register, the registered office of VitalisPharma is in 1140 Evere.
What is the equity of VitalisPharma?
At the close of the 2025 financial year, the equity of VitalisPharma amounts to -12,576 €, a solvency of -27.7% of total assets.
Who manages VitalisPharma?
The register lists 2 active mandates at VitalisPharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of VitalisPharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →